Expanding on our history as a market leader in clinical diagnostics, Somagen has assembled a group of leading suppliers to support the rapidly advancing field of Molecular Pathology. From liquid biopsy sample stabilization to quality control for Next Generation Sequencing, Somagen supports our clinical partners with quality products designed to ensure accurate and clinically actionable patient results.
For more information on our innovative product* offers, please see below.
Streck’s patented portfolio of stabilization solutions enables laboratories to mitigate and limit pre-analytical variation in critical samples, ease handling concerns while allowing for room temperature storage, cold-chain free shipping and batch processing. Streck’s direct draw blood collection tubes and preservation products for biofluids are recognized worldwide. Target analytes include cell-free DNA, cell-free RNA, clusters of differentiation antigens, extracellular vesicles and cellular nucleic acids.
Spike-In Quality Control
AccuGenomics improves the diagnostic accuracy and confidence in next generation precision medicine assays through the use of their exclusively-licensed SNAQ™-SEQ internal standards technology. SNAQ-SEQ enables a host of high-sensitive NGS applications including improved ctDNA detection of rare variants and rapid adventitious agent detection in cell therapy manufacturing including CAR-T cells and genetically-engineered stem cells.
* Some products may not be authorized for sale in Canada. In addition, some products may be for Research Use Only (RUO) – not for clinical diagnostic purposes. Please contact Somagen for specific enquiries.